Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | ||||||
{[ item.p_purity ]} | {[ item.pr_size ]} | Inquiry |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price) ]} |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price) ]} | {[ item.pr_usastock ]} | in stock Inquiry - | {[ item.pr_chinastock ]} | {[ item.pr_remark ]} in stock Inquiry - | Login | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
CAS No. : | 621-42-1 | MDL No. : | MFCD00002263 |
Formula : | C8H9NO2 | Boiling Point : | No data available |
Linear Structure Formula : | - | InChI Key : | QLNWXBAGRTUKKI-UHFFFAOYSA-N |
M.W : | 151.16 | Pubchem ID : | 12124 |
Synonyms : |
|
Chemical Name : | N-(3-Hydroxyphenyl)acetamide |
Signal Word: | Warning | Class: | |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | |
Hazard Statements: | H315-H319-H335 | Packing Group: | |
GHS Pictogram: |
Metacetamol (CAS: 621-42-1) can be used in the preparation of Bosutinib (SKI-606) (CAS: 380843-75-4). Bosutinib, a small molecule that inhibits BCR-ABL and src tyrosine kinases, is utilized for treating chronic myelogenous leukemia.
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
43.3% | EXAMPLE 77 2-(3-Acetylaminophenoxymethyl)-4-nitrobenzoic acid methyl ester (3) In accordance with general method U, 1.50 g (10.86 mmol) of potassium carbonate are suspended in 15 ml of acetone, 1.80 g (11.90 mmol) of 3-acetamidophenol are then added and the mixture is stirred for 15 min. 2.44 g (8.91 mmol) of (2) are added to the mixture. Yield: 1.33 g (43.3%); melting point: 139.2 C. C17H16N2O6 (Mr=344.33); GC (method 3) 23.07 min 1H-NMR (DMSO-d6) in ppm: 9.95 (s, 1H, -NH), 8.45 (d, 1H, J=1.98 Hz, aryl H), 8.27 (m, 1H, aryl H), 8.12 (d, 1H, J=8.54 Hz, aryl H), 7.37 (s, 1H, aryl H), 7.21-7.16 (m, 2H, aryl H), 6.71-6.68 (m, 1H, aryl H), 5.44 (s, 2H, -CH2-O), 3.86 (s, 3H, -O-CH3) 13C-NMR (DMSO-d6) in ppm: 168.75 (-NH-C=O-), 166.00 (-C=O), 158.41 (C1'), 149.75 (C4), 141.00 (C2), 140.77 (C3'), 134.48 (C1), 132.10 (C6), 130.02 (C5'), 123.08 (C3), 122.64 (C5), 112.37 (C4'), 109.49 (C6'), 105.94 (C2'), 65.01 (-CH2-O), 52.16 (-O-CH3), 24.41 (-NH=O-CH3) IR (ATR) (cm-1): 1729, 1719, 1606, 1349, 1289, 1253, 1158, 1057, 771, 727 MS m/z (%): 344 (10), 327 (10), 271 (3), 194 (100), 148 (44). General Method UFor further reaction of the brominated educt with substituted phenols, the stated amount of potassium carbonate is suspended in acetone in a 250 ml three-necked flask. The phenol to be deprotonated is added and the mixture is stirred at room temperature for 15 min. The brominated benzoic acid methyl ester is then added to the mixture and, after heating to 70 C., the mixture is refluxed for 6 h. The acetone is removed in vacuo and the residue is extracted by shaking several times with EtOAc. After acidification of the aqueous phase with 20% strength HCl, the combined organic phases are concentrated in vacuo after drying (Na2SO4) and the residue is purified by recrystallization with methanol. |
[ 23478-25-3 ]
N-(3-Hydroxyphenyl)cinnamamide
Similarity: 0.85
[ 16375-90-9 ]
N-(4-hydroxy-3-methylphenyl)acetamide
Similarity: 0.84
[ 5472-37-7 ]
N-(2-Amino-4-methoxyphenyl)acetamide
Similarity: 0.84
[ 3749-51-7 ]
4-Hydroxy-6-methylpyridin-2(1H)-one
Similarity: 0.88
[ 23478-25-3 ]
N-(3-Hydroxyphenyl)cinnamamide
Similarity: 0.85
[ 16375-90-9 ]
N-(4-hydroxy-3-methylphenyl)acetamide
Similarity: 0.84
[ 23478-25-3 ]
N-(3-Hydroxyphenyl)cinnamamide
Similarity: 0.85
[ 16375-90-9 ]
N-(4-hydroxy-3-methylphenyl)acetamide
Similarity: 0.84
[ 5472-37-7 ]
N-(2-Amino-4-methoxyphenyl)acetamide
Similarity: 0.84